Publication Name	World Journal of Gastrointestinal Oncology
Manuscript ID	125732
DOI	10.4251/wjgo.125732
Country	China

Category	Oncology
Manuscript Type	Retrospective Study
Article Title	Neoadjuvant chemotherapy vs chemoradiotherapy for locally advanced gastric cancer: A propensity score-matched study
Manuscript Source	Unsolicited Manuscript
All Author List	Yi-Fan Wang, Xia-Xi Qiao, Quan-Ming Liu, Yong-Wen Song, Hui Fang, Bo Chen, Ning-Ning Lu, Shu-Nan Qi, Hao Jing, Shu-Lian Wang, Ye-Xiong Li, Jing Jin, Yuan Tang and Ning Li
Funding Agency and Grant Number	Funding Agency Grant Number National Cancer Center Climbing Fund No. NCC202414002
Corresponding Author	Ning Li, Full Professor, Department of Radiation Oncology, Shanxi Province Cancer Hospital Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences Cancer Hospital Affiliated to Shanxi Medical University Cancer Hospital Affiliated to Shanxi Medical University, No. 3 Zhigongxin Street, Taiyuan 030013, Shanxi Province, China. lee_ak@163.com
Key Words	Gastric adenocarcinoma; Neoadjuvant therapy; Chemotherapy; Chemoradiotherapy; Postoperative complications
Core Tip	Using propensity score matching, this study compared neoadjuvant chemoradiotherapy (nCRT) with neoadjuvant chemotherapy in locally advanced gastric cancer (LAGC), focusing on postoperative complications and pathological outcomes. No statistically significant difference in postoperative complications was observed between the two groups, whereas nCRT was associated with significantly higher pathological complete response and favorable tumor regression rates (1-2). These findings suggest that nCRT is a feasible neoadjuvant strategy for LAGC and may provide improved pathological responses, warranting further prospective evaluation.
Citation	Wang YF, Qiao XX, Liu QM, Song YW, Fang H, Chen B, Lu NN, Qi SN, Jing H, Wang SL, Li YX, Jin J, Tang Y, Li N. Neoadjuvant chemotherapy vs chemoradiotherapy for locally advanced gastric cancer: A propensity score-matched study. World J Gastrointest Oncol 2026; In press DOI: https://doi.org/10.4251/wjgo.125732

Received	2026-07-15 07:09
Peer-Review Started	2026-07-15 07:10
First Decision by Editorial Office Director
Return for Revision	2026-08-25 14:25
Revised	2026-09-07 15:01
Publication Fee Transferred	2026-09-25 03:16
Second Decision by Editor	2026-10-30 07:37
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2026-10-30 10:22
Articles in Press	2026-10-30 10:22
Edit the Manuscript by Language Editor
Typeset the Manuscript

ISSN	1948-5204 (online)
Open Access	This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright	©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com